Tau Unbound
Tau Unbound
Podcast Description
Hosted by TAU graduate, veteran diplomat and lecturer, Ido Aharoni Aronoff, TAU Unbound celebrates the great talent of Tel Aviv University. Tens of episodes hosting world class experts and researchers, expose our eclectic audience to new and enriching information in a wide range of areas: machine learning (AI), medicine, geo-politics and Middle East, diplomacy, behavioral studies, space, environment, law, future of work, immigration and many more.
Podcast Insights
Content Themes
The podcast covers a wide range of themes such as nanotechnology, political and economic analysis of Israel's future, social issues including the integration of ultra-Orthodox communities, and trauma and resilience following crises. For example, episodes feature discussions on the implications of the October 7th crisis and explore advancing fields such as artificial intelligence in medicine.
Hosted by TAU graduate, veteran diplomat and lecturer, Ido Aharoni Aronoff, TAU Unbound celebrates the great talent of Tel Aviv University. Tens of episodes hosting world class experts and researchers, expose our eclectic audience to new and enriching information in a wide range of areas: machine learning (AI), medicine, geo-politics and Middle East, diplomacy, behavioral studies, space, environment, law, future of work, immigration and many more.
Our guest in this new episode is an academic super star: Prof. Carmit Levy who is the Chair of the Department of Human Molecular Genetics & Biochemistry at the Gray Faculty of Medicine. Levy is a renowned researcher in the area of skin cancer.
Prof. Levy and her team recently made a groundbreaking discovery involving a protein called Ly6a, which acts as a “brake” on the immune system. This protein, expressed both after UV exposure and in tumors, prevents immune cells from attacking cancer effectively. In experimental studies, the team showed that blocking Ly6a with a specific antibody reactivated the immune response, causing tumors to shrink—even in cases resistant to existing immunotherapies.This research, published in Nature Communications, not only advances our understanding of the immune system but also points toward entirely new treatment possibilities. Join us as we explore with Prof. Levy how this discovery was made, its future potential, and what it means for the fight against cancer.
__________________
Tel Aviv 360, Israel's largest and most diverse podcast about research and innovation
• Tel Aviv 360 in Facebook ◄ https://360tau.com/Facebook
• Tel Aviv 360 in WhatsApp (Silent group) ◄ https://360tau.com/WhatsApp
• Tel Aviv 360 in Spotify ◄ https://360tau.com/Spotify
• Tel Aviv 360 official website ◄ https://360tau.com
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.